Clik here to view.
新研究调查Masimo氧储备指数(Oxygen Reserve Index™, ORi™)在肥胖患者中的功用
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布了佛罗里达州迈阿密召开的麻醉技术学会(STA)年会上呈报的一份摘要的内容。该研究中，加州大学戴维斯分校医学院的研究人员评估了Masimo氧储备指数(Oxygen Reserve Index™,...
View ArticleClik here to view.
武田连续第三年入选全球最具可持续性企业百强
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited)[TOKYO:4502](“Takeda”)今年第三年被Corporate...
View ArticleClik here to view.
欧盟委员会核准ADCETRIS® (brentuximab...
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布，欧盟委员会(EC)延长了现有的ADCETRIS® (brentuximab...
View ArticleClik here to view.
Canon Medical Systems Corporation to Participate in the AOCR 2018
OOTAWARA, Japan Canon Medical Systems Corporation will participate in the AOCR 2018, the 17th Asian Oceanian Congress of Radiology and the 71st Annual Conference of the Indian Radiology and Imaging...
View ArticleClik here to view.
Dr. Reddy’s Q3 and 9M FY18 Financial Results
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the third quarter and nine months ended December 31,...
View ArticleClik here to view.
ファインデックス、キヤノンメディカルシステムズ株式会社との業務提携の基本合意に関するお知らせ
東京 （ビジネスワイヤ） — 株式会社ファインデックス（東証一部：3649 本社：東京 社長：相原輝夫、以下ファインデックス）は、本日開催の取締役会において、以下のとおり、キヤノンメディカルシステムズ株式会社（本社：栃木県大田原市、社長：瀧口登志夫）との間で、医療情報システム事業に関する業務提携を行うことについての基本的な合意文書を締結することを決議いたしましたので、お知らせいたします。...
View ArticleClik here to view.
Canon Medical Systems Corporation to Participate in Arab Health 2018
OOTAWARA, Japan Canon Medical Systems Corporation will participate in Arab Health 2018 in Dubai (UAE) from January 29 to February 1, 2018. Canon Medical Systems Corporation will be showcasing...
View ArticleClik here to view.
欧州委員会がアドセトリス（ブレンツキシマブ・ベドチン）を過去に1種類の全身療法を受けているCD30陽性皮膚T細胞リンパ腫の治療薬として承認することで、患者...
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社(TSE:...
View ArticleClik here to view.
Newly Expanded Evidence from Clinical Practice on NaturalVue® (etafilcon A) 1...
ATLANTA Visioneering Technologies, Inc (ASX: VTI), a US-based medical device company (‘Visioneering’ or ‘The Company’) engaged in the design, manufacture, sale and distribution of its proprietary...
View ArticleClik here to view.
Otsuka Awarded Grant to Advance Development of Novel Anti-Tuberculosis...
TOKYO & PRINCETON, N.J. Otsuka Pharmaceutical Co., Ltd., and its indirect subsidiary Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka), announce that the latter has been...
View ArticleClik here to view.
Takeda’s Zika Vaccine Candidate Receives U.S. FDA Fast Track Designation
OSAKA, Japan Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TAK-426, Takeda’s...
View ArticleClik here to view.
Aravive Biologics and WuXi Biologics to Form Strategic Manufacturing...
HOUSTON & WUXI, China Aravive Biologics, Inc. and WuXi Biologics (WuXi Bio, 02269.HK) today announced plans to expand their biologics manufacturing collaboration, based on the rapid success...
View ArticleClik here to view.
Avita Medical Announces Five RECELL® Abstracts Accepted for Presentation at...
VALENCIA, Calif. & MELBOURNE, Australia Avita Medical (ASX – AVH, OTCQX: AVMXY) announced that five abstracts highlighting the compelling clinical data and health economic benefits of RECELL® in...
View ArticleClik here to view.
Hoya Reports Third Quarter Financial Results: Record High Revenues
TOKYO Hoya Corporation (TOKYO:7741) today announced financial results for the third quarter ended December 31, 2017. During the quarter, revenues for the HOYA Group increased 11.6% year on year,...
View ArticleClik here to view.
Astellas Reports Financial Results for the First Nine Months of FY2017
TOKYO Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced the financial results for the first nine months of fiscal year 2017 ending March 31, 2018...
View ArticleAvita Medical Second Quarter 2018 Quarterly Cash Flow Report and Company Update
VALENCIA, Calif. & MELBOURNE, Australia Avita Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns,...
View ArticleClik here to view.
武田的寨卡候选疫苗进入美国FDA快通道审理
日本大阪 (美国商业资讯) — 武田药品工业株式会社[TSE: 4502]（以下简称“武田”）今天宣布，武田的纯化、灭活、铝佐剂、全寨卡病毒候选疫苗TAK-426进入美国食品药品管理局(FDA)快通道审理。...
View ArticleClik here to view.
Notification of the Results of the Phase III Clinical Study of HP-3070...
MIAMI Hisamitsu Pharmaceutical Co., Ltd. (Headquarters: Tosu City, Saga Prefecture, President and Chief Executive Officer (CEO): Hirotaka Nakatomi (hereinafter “Hisamitsu Pharmaceutical”), in...
View ArticleClik here to view.
“3D Printing 2018”開催-時代を変える。ものづくりは新たなステージへ-
東京 （ビジネスワイヤ） — 株式会社JTBコミュニケーションデザインは、2018年2月14日から16日まで、東京ビッグサイトにて、3D Printing 2018-Additive Manufacturing Technology Exhibition-を開催します。40社を超える新規出展者を含む 88社(149 小間 /...
View ArticleClik here to view.
3D Printing 2018_Japan, Brings You the Latest Information on the Cutting Edge...
TOKYO The JTB Communication Design, Inc. will be holding “3D Printing 2018” – the Cutting Edge 3D Printing Technologies exhibitions, now in its 4th year – on February 14th -16th, 2018, at the Tokyo...
View Article